Apollon Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.97M | Buy |
35,780
+871
| +2% | +$96.6K | 0.08% | 219 |
|
|
2025
Q1 | $3.91M | Sell |
34,909
-3,090
| -8% | -$346K | 0.09% | 211 |
|
|
2024
Q4 | $3.51M | Buy |
37,999
+11,000
| +41% | +$1.02M | 0.08% | 230 |
|
|
2024
Q3 | $2.26M | Sell |
26,999
-276
| -1% | -$23.1K | 0.06% | 277 |
|
|
2024
Q2 | $1.87M | Sell |
27,275
-5,711
| -17% | -$392K | 0.06% | 310 |
|
|
2024
Q1 | $2.42M | Sell |
32,986
-2,041
| -6% | -$150K | 0.08% | 242 |
|
|
2023
Q4 | $2.84M | Buy |
35,027
+18,444
| +111% | +$1.49M | 0.1% | 191 |
|
|
2023
Q3 | $1.24M | Buy |
16,583
+218
| +1% | +$16.3K | 0.06% | 302 |
|
|
2023
Q2 | $1.26M | Buy |
16,365
+1,097
| +7% | +$84.5K | 0.06% | 331 |
|
|
2023
Q1 | $1.27M | Buy |
15,268
+1,954
| +15% | +$162K | 0.08% | 268 |
|
|
2022
Q4 | $1.14M | Buy |
13,314
+1,031
| +8% | +$88.5K | 0.08% | 264 |
|
|
2022
Q3 | $758K | Buy |
12,283
+1,162
| +10% | +$71.7K | 0.06% | 335 |
|
|
2022
Q2 | $687K | Buy |
11,121
+1,446
| +15% | +$89.3K | 0.06% | 357 |
|
|
2022
Q1 | $575K | Sell |
9,675
-26,553
| -73% | -$1.58M | 0.04% | 426 |
|
|
2021
Q4 | $1.18M | Buy |
36,228
+27,295
| +306% | +$887K | 0.09% | 246 |
|
|
2021
Q3 | $624K | Buy |
8,933
+4,362
| +95% | +$305K | 0.09% | 228 |
|
|
2021
Q2 | $315K | Buy |
4,571
+194
| +4% | +$13.4K | 0.06% | 276 |
|
|
2021
Q1 | $283K | Buy |
+4,377
| New | +$283K | 0.05% | 278 |
|
|
2020
Q3 | – | Sell |
-2,302
| Closed | -$177K | – | 355 |
|
|
2020
Q2 | $177K | Buy |
+2,302
| New | +$177K | 0.1% | 121 |
|